Evocutis announces 2013 interim results

Published: 3-Apr-2013
Finance

Revenue reaches £226,000


Evocutis plc, the UK dermatology company, has announced its unaudited interim results for the six months ended 31 January, 2013.

The company reported a revenue of £226,000, up from £344,000 in H1 2012, while the cash balance totalled £1,030,000 at 31 January 2013. Adjusted operating loss totalled £476,000, while basic loss per share equalled 0.28p per share.

Operation highlights in the reporting period include the launch of LabSkin for direct sale in September 2012, and laboratory studies of LabSkin, which demonstrated its value as a living model system for studies of transdermal drug delivery, complementing the use of excised, non-living human or pig skin systems.

  • Companies:
  • Evocutis
See more

You may also like

Skin Care

Venn Life Sciences acquires trading assets of Evocutis

Read more
Including intellectual property rights to Labskin and anti-acne compound SYN1113

Trending Articles

  1. Helen of Troy buys nail brand Olive & June for $225 million The brand owner will build on Olive & June’s consumer perception strength and help expand its availability
  2. The Ordinary co-founder Nicola Kilner to cede Deciem CEO role Kilner will step down as CEO at the end of the year, but will remain as co-founder and continue to be involved
  3. e.l.f. Beauty hits back at ‘unsubstantiated’ short seller report A 48-page report issued by Muddy Waters has alleged that the US beauty giant had “inflated” its revenue and profits
  4. Space NK full-year sales jump as Gen Z shoppers drive sales The UK retailer is also expanding its portfolio with ten additional stores, which has already seen a store open in Sheffield
  5. THG CEO Matthew Moulding mulling sale of company’s £250 million headquarters A real estate investor is alleged to be eyeing up the British beauty and fashion retail group’s Icon Business Park site in Manchester

Upcoming event

Cosmoprof India 2024

5-7 December 2024 | Mumbai, India See all

You may also like

Skin Care

Venn Life Sciences acquires trading assets of Evocutis

Including intellectual property rights to Labskin and anti-acne compound SYN1113
Skin Care

The Ordinary co-founder Nicola Kilner to cede Deciem CEO role

Kilner will step down as CEO at the end of the year, but will remain as co-founder and continue to be involved
Colour Cosmetics

Helen of Troy buys nail brand Olive & June for $225 million

The brand owner will build on Olive & June’s consumer perception strength and help expand its availability
Finance

e.l.f. Beauty hits back at ‘unsubstantiated’ short seller report

A 48-page report issued by Muddy Waters has alleged that the US beauty giant had “inflated” its revenue and profits
Finance

Space NK full-year sales jump as Gen Z shoppers drive sales

The UK retailer is also expanding its portfolio with ten additional stores, which has already seen a store open in Sheffield
Packaging

Packaging firms Berry Global and Amcor to merge

The combined company is expected to reach US$650 million in annual earnings
Finance

Haut.AI recognised as one of Eastern Europe’s fastest-growing startups

Haut.AI has proudly secured the 26th position on the Sifted 30 leaderboard, which highlights the fastest-growing startups in Eastern Europe and the Baltics for 2024
Subscribe now